SCHOTT Pharma invests in RTU cartridge capability growth
Drug containment and supply options supplier SCHOTT Pharma has introduced an funding of greater than €100m ($114m) to increase its manufacturing capability for sterile ready-to-use (RTU) cartridges at its website in Lukácsháza, Hungary.
The brand new facility will create 100 jobs.
RTU cartridges are important for storing glucagon-like peptide-1 medication, biologics, insulin and hormone therapies used for treating diabetes, weight problems and different immunological situations.
It’ll additional lengthen the location’s manufacturing capabilities for high-value options.
SCHOTT Pharma plans to implement a totally built-in and automatic manufacturing course of with minimal handbook intervention, making certain the supply of sterile merchandise.
The power will even function a brand new washing line and a steam sterilisation course of for cartridges, geared toward reducing the environmental affect of the operations.
SCHOTT Pharma CEO Andreas Reisse acknowledged: “To fulfill rising demand, we’re increasing our capabilities and presence within the diabetes and weight problems fields. That’s the reason we’re investing greater than €100m in our plant in Hungary.”
In June 2024, the corporate opened a brand new facility on the similar website, which has already begun producing high-quality prefillable glass syringes.
With an extra 120 staff, the location has elevated its manufacturing capability to satisfy the rising demand for these essential parts within the healthcare business.
Lukácsháza website supervisor Eva Szabó acknowledged: “We wish to specific our sincerest gratitude to the Ministry of International Affairs and Commerce for its assist of those two growth initiatives.
“Lukácsháza shouldn’t be solely an essential location for making certain provide safety to prospects within the area but additionally makes an essential contribution to SCHOTT Pharma’s world development technique.”
Lukácsháza will change into the second SCHOTT Pharma website, after St Gallen in Switzerland, for sterile cartridge manufacturing.
The corporate’s portfolio contains a wide range of supply methods and drug containment options for injectable medication, corresponding to prefillable glass and polymer syringes, cartridges, ampoules and vials.